HWM
AZN icon

Hemington Wealth Management’s AstraZeneca AZN Stock Holding History

Hemington Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7K Buy
51
+30
+143% +$4.54K ﹤0.01% 1002
2025
Q2 		$2K Sell
21
-10
-32% -$1.4K ﹤0.01% 1283
2025
Q1 		$4K Hold
31
– – ﹤0.01% 1092
2024
Q4 		$3K Hold
31
– – ﹤0.01% 1136
2024
Q3 		$4K Buy
+31
New +$5K ﹤0.01% 986

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Hemington Wealth Management's AZN Position: Q3 2025 in Review

Hemington Wealth Management increased its AstraZeneca (AZN) stake by 143% in Q3 2025, buying an estimated $4.54K and bringing the position to 51 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Hemington Wealth Management first reported a position in AZN in Q3 2024 and has held it in 5 quarters since. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Hemington Wealth Management held 51 shares of AstraZeneca worth $7K as of Q3 2025.
  • Hemington Wealth Management bought 30 AstraZeneca shares in Q3 2025, an estimated $4.54K.
  • AstraZeneca made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1002 holding.
  • Hemington Wealth Management first reported a position in AstraZeneca in Q3 2024 and has held it in 5 quarters since.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.